Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:administeredBy |
immunocompromised patients
|
| gptkbp:approvedBy |
1989
|
| gptkbp:ATCCode |
J05AB06
|
| gptkbp:CASNumber |
82410-32-0
|
| gptkbp:contraindication |
severe neutropenia
hypersensitivity to ganciclovir |
| gptkbp:discoveredBy |
gptkb:Syntex
|
| gptkbp:drugClass |
antiviral
|
| gptkbp:eliminationHalfLife |
2.5-4 hours
|
| gptkbp:hasMolecularFormula |
C9H13N5O4
|
| https://www.w3.org/2000/01/rdf-schema#label |
ganciclovir
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits viral DNA polymerase
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prodrugOf |
gptkb:valganciclovir
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
gptkb:anemia
fever rash neutropenia thrombocytopenia renal toxicity |
| gptkbp:synonym |
Cytovene
DHPG |
| gptkbp:usedFor |
gptkb:cytomegalovirus_infection
herpes simplex virus infection varicella zoster virus infection |
| gptkbp:bfsParent |
gptkb:virus
|
| gptkbp:bfsLayer |
5
|